Doctor profile · Federal record
Dr. GEORGE YAGHMOUR
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · LOS ANGELES, CA
- NPI 1669604849
- Accepts Medicare
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1441 EASTLAKE AVE
LOS ANGELES, CA 900890112
(323) 865-3950 - Mailing address
-
PO BOX 31309
LOS ANGELES, CA 900310309
Credentials & registration
- NPI registered
- August 2009 — 17 yrs on file
- Profile last updated
- November 16, 2020
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A140245
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669604849. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
397
Distinct HCPCS
6
Medicare allowed
$43,152
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 219 | 43 | $84 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 64 | 19 | $126 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 63 | 28 | $148 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 16 | $138 | |
99239 |
Hospital discharge day management, more than 30 minutes | 19 | 18 | $123 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $185 |
In context: peer comparison
Among 50 peers in this city , average services per provider: 1,244. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$466,544
Transactions
353
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 40 | $64,656.26 | |
| JAZZ PHARMACEUTICALS INC. | 41 | $54,371.35 | |
| E.R. Squibb & Sons, L.L.C. | 36 | $53,994.41 | |
| Astellas Pharma US Inc | 35 | $48,788.62 | |
| Rigel Pharmaceuticals, Inc. | 23 | $41,560.85 | |
| SOBI, INC | 17 | $36,190.16 | |
| Blueprint Medicines Corporation | 35 | $35,015.96 | |
| Stemline Therapeutics Inc. | 17 | $24,923.40 | |
| Alexion Pharmaceuticals, Inc. | 20 | $23,789.58 | |
| Incyte Corporation | 20 | $21,056.52 | |
| Kite Pharma, Inc. | 17 | $14,020.06 | |
| Novartis Pharmaceuticals Corporation | 25 | $9,590.12 | |
| ABBVIE INC. | 11 | $9,456.72 | |
| Secura Bio, Inc. | 7 | $8,353.72 | |
| SERVIER PHARMACEUTICALS LLC | 9 | $5,919.96 |